US Consul General Charles Goodman chaired the launch of a new treatment, the endoscopic gastroplasty of the sleeve (ESG), developed by the American company Boston Scientific.
ESG will be available in Pakistan exclusively at the Sindh Institute of Advanced Gastroenterology (SIAG) in Karachi.
The launch of September 1st has underlined the benefits that this minimally invasive procedure will bring to patients struggling with obesity and conditions such as diabetes. ESG represents a significant progress in Pakistan’s healthcare by facing a critical challenge of public health with innovative techniques.
The event underlined US medical innovation and reinforced America’s commitment to enhance its cooperation with Pakistan, a statement issued by the US Consulate in Karachi.
Consul General Goodman underlined the leadership of US companies to address significant public health challenges, such as obesity and related diseases.
He said: “The launch of the endoscopic gastroople of the sleeve (ESG) demonstrates how American innovation leads to transformative healthcare solutions worldwide.
“This collaboration between Boston Scientific and Siag reflects the strong US-Pakistan partnership, providing advanced medical technologies to tackle obesity, diabetes and heart disease.
“Together, we extend access to health care that changes life for communities in Sindh and Beyond.”
American excellence and innovation continue to support mutual security, security and prosperity, facing global challenges and promoting lives that improve lives.
More than 65 US companies, including many Fortune 500 companies and Blue-Chip, have created a strong presence in Pakistan for decades. This collaboration between Boston Scientific and Siag enhances this heritage, promoting a common US-Pakistan vision for accessible, high quality health care, deepening bonds in medical innovation and public health.
a href=”https://www.geo.tv/latest/621938-us-envoy-launches-esg-treatment-at-gastroenterology-institute-in-karachi”>Source link
